Korro Bio, Inc
Price
FilingsNewest: Form 4, insider tradeNov 13 →Insiders13 insiders bought $21.7M in 16 open-market buys. 6 insiders sold $6.7M, 33 of 39 sales on a 10b5-1 plan.→HoldersLynx1 11.2%Nantahala 9.6%Nea 9.5%→Financing →PeersClosest companies: DSGN, TNYA, MGX→
From the filings
Figures
- Revenue
- $1.3Mlast 12 months
- Net income
- −$106.1Mlast 12 months
- Operating cash flow
- −$67.9Mlast 12 months
- Cash and equivalents
- $40.2Mat the last balance sheet
- Shares outstanding
- 13.7M shareson issue